Selinexor in Combination With Immunomodulator （Thalidomide/Pomalidomide/Lenalidomide）in RRMM

Clinical trial NCT04941937 · UNKNOWN

Trial details

NCT number: NCT04941937
Sponsor: Juan Du
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2022-01-27
Primary completion: 2025-12-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.